JPMorgan Chase & Co’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.23M | Buy |
443,375
+4,069
| +0.9% | +$20.5K | ﹤0.01% | 3263 |
|
2025
Q1 | $2.85M | Sell |
439,306
-1,367,711
| -76% | -$8.86M | ﹤0.01% | 3035 |
|
2024
Q4 | $13.3M | Buy |
1,807,017
+720,690
| +66% | +$5.29M | ﹤0.01% | 2034 |
|
2024
Q3 | $8.14M | Sell |
1,086,327
-168,971
| -13% | -$1.27M | ﹤0.01% | 2292 |
|
2024
Q2 | $11.2M | Buy |
1,255,298
+792,051
| +171% | +$7.05M | ﹤0.01% | 2039 |
|
2024
Q1 | $4.69M | Buy |
463,247
+236,700
| +104% | +$2.4M | ﹤0.01% | 2616 |
|
2023
Q4 | $2.28M | Buy |
226,547
+71,557
| +46% | +$720K | ﹤0.01% | 3065 |
|
2023
Q3 | $1.45M | Sell |
154,990
-78,529
| -34% | -$736K | ﹤0.01% | 3200 |
|
2023
Q2 | $5.73M | Buy |
233,519
+107,164
| +85% | +$2.63M | ﹤0.01% | 2405 |
|
2023
Q1 | $2.94M | Sell |
126,355
-23,264
| -16% | -$541K | ﹤0.01% | 2805 |
|
2022
Q4 | $3.79M | Buy |
149,619
+65,984
| +79% | +$1.67M | ﹤0.01% | 2565 |
|
2022
Q3 | $1.61M | Buy |
83,635
+679
| +0.8% | +$13.1K | ﹤0.01% | 3058 |
|
2022
Q2 | $2.11M | Buy |
82,956
+2,983
| +4% | +$75.9K | ﹤0.01% | 2967 |
|
2022
Q1 | $2.06M | Sell |
79,973
-101,849
| -56% | -$2.62M | ﹤0.01% | 3149 |
|
2021
Q4 | $7.61M | Sell |
181,822
-754
| -0.4% | -$31.6K | ﹤0.01% | 2287 |
|
2021
Q3 | $7.95M | Sell |
182,576
-27,652
| -13% | -$1.2M | ﹤0.01% | 2240 |
|
2021
Q2 | $9.94M | Buy |
210,228
+89
| +0% | +$4.21K | ﹤0.01% | 2150 |
|
2021
Q1 | $10.8M | Buy |
210,139
+64,841
| +45% | +$3.32M | ﹤0.01% | 2074 |
|
2020
Q4 | $3.89M | Buy |
145,298
+27,775
| +24% | +$744K | ﹤0.01% | 2580 |
|
2020
Q3 | $4.43M | Sell |
117,523
-4,008
| -3% | -$151K | ﹤0.01% | 2300 |
|
2020
Q2 | $4.98M | Sell |
121,531
-124
| -0.1% | -$5.08K | ﹤0.01% | 2156 |
|
2020
Q1 | $4.17M | Buy |
121,655
+21,914
| +22% | +$751K | ﹤0.01% | 2128 |
|
2019
Q4 | $1.26M | Buy |
+99,741
| New | +$1.26M | ﹤0.01% | 2936 |
|